Table 1.
Characteristics | No. of studies (no. of participants) |
---|---|
Eligible studies | |
Total no. of trials (no. of participants) | 17 (19,516) |
Follow‐up at least three years | 11 (12,761) |
Total no. of outcome events | 2134 |
Median (IQR) % female | 53 (49–59) |
Median (IQR) age (years) | 74 (65–80) |
Country | |
American | 12 (17,041) |
European | 4 (2335) |
China | 1 (140) |
Inflammatory markers | |
CRP | 11 (14,324) |
IL‐6 | 15 (18,710) |
TNF‐α | 5 (7183) |
IQR, interquartile range.